[go: up one dir, main page]

CA2132708A1 - Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding - Google Patents

Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding

Info

Publication number
CA2132708A1
CA2132708A1 CA002132708A CA2132708A CA2132708A1 CA 2132708 A1 CA2132708 A1 CA 2132708A1 CA 002132708 A CA002132708 A CA 002132708A CA 2132708 A CA2132708 A CA 2132708A CA 2132708 A1 CA2132708 A1 CA 2132708A1
Authority
CA
Canada
Prior art keywords
aggregation
fluorescent dyes
fluorescence immunoassays
serum binding
dyes free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002132708A
Other languages
French (fr)
Other versions
CA2132708C (en
Inventor
Robert F. Devlin
Walter B. Dandliker
Peter O. G. Arrhenius
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diatron Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2132708A1 publication Critical patent/CA2132708A1/en
Application granted granted Critical
Publication of CA2132708C publication Critical patent/CA2132708C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036—Porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0834—Compounds having one or more O-Si linkage
    • C07F7/0838—Compounds with one or more Si-O-Si sequences
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/19—Rubella virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

Fluorescence immunoassays methods are provided which use fluorescent dyes which are free of aggregation and serum binding. Such immunoassay methods are thus, particularly useful for the assay of biological fluids, such as serum, plasma, whole blood and urine.
CA002132708A 1992-03-23 1993-03-23 Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding Expired - Fee Related CA2132708C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85617692A 1992-03-23 1992-03-23
US07/856,176 1992-03-23
PCT/US1993/002470 WO1993019366A1 (en) 1992-03-23 1993-03-23 Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding

Publications (2)

Publication Number Publication Date
CA2132708A1 true CA2132708A1 (en) 1993-09-30
CA2132708C CA2132708C (en) 2005-05-10

Family

ID=25323005

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002132708A Expired - Fee Related CA2132708C (en) 1992-03-23 1993-03-23 Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding

Country Status (3)

Country Link
EP (1) EP0632893A4 (en)
CA (1) CA2132708C (en)
WO (1) WO1993019366A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5880287A (en) * 1990-05-15 1999-03-09 Hyperion, Inc. Polyoxyhydrocarbyl related products and methods for fluorescence assays
US5919922A (en) * 1990-05-15 1999-07-06 Hyperion, Inc. Fluorescent dyes free of aggregation and serum binding
US6060598A (en) * 1990-05-15 2000-05-09 Hyperion, Inc. Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding
US5824799A (en) * 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6238931B1 (en) 1993-09-24 2001-05-29 Biosite Diagnostics, Inc. Fluorescence energy transfer in particles
US7083984B2 (en) 1993-09-24 2006-08-01 Biosite, Inc. Hybrid phthalocyanine derivatives and their uses
US7322927B2 (en) 1993-09-24 2008-01-29 Biosite, Inc. Hybrid phthalocyanine derivatives and their uses
AU5318896A (en) * 1995-03-23 1996-10-08 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US5876935A (en) * 1997-01-08 1999-03-02 Dade Behring Inc. Luminescent specific binding assay
CN1344293A (en) * 1998-11-25 2002-04-10 海珀里昂有限公司 Water soluble fluorescent dyes free of aggregation and serum binding and related products and methods
EP1780213A1 (en) 2005-10-27 2007-05-02 3M Innovative Properties Company Silicon-urea-azolides, their preparation and use in the preparation of silicones with isocyanate terminal groups
WO2010019967A1 (en) * 2008-08-15 2010-02-18 Georgetown University Fluorescent cdk inhibitors for treatment of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0645681B2 (en) * 1986-02-05 1994-06-15 美浜 久春 Modified hem
EP0335902B1 (en) * 1986-12-15 1993-12-01 British Technology Group Usa Inc. Monomeric phthalocyanine reagents
EP0528991B1 (en) * 1990-05-15 2001-09-26 Diatron Corporation Detectably labelled marker component comprising a fluorophore moiety , fluorescent probe comprising the marker component and uses thereof.
EP0529002B1 (en) * 1990-05-15 2001-10-04 Hyperion, Inc. Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes
DE69214328T2 (en) * 1991-03-05 1997-02-20 Hitachi Chemical Co Ltd Water soluble tetrazaporphin and fluorescent label

Also Published As

Publication number Publication date
EP0632893A1 (en) 1995-01-11
EP0632893A4 (en) 1997-01-02
WO1993019366A1 (en) 1993-09-30
CA2132708C (en) 2005-05-10

Similar Documents

Publication Publication Date Title
CA2223418A1 (en) Polyoxyhydrocarbyl related products and methods for fluorescence assays
AU642324B2 (en) Fluorescent compound, complex, reagent, and specific binding assay employing said reagent
AU5665696A (en) Novel methods for the assay of troponin i and t and complexe s of troponin i and t and selection of antibodies for use in immunoassays
AU8011294A (en) Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds
CA2262739A1 (en) Low background multi-well plates for fluorescence measurements of biological and biochemical samples
DE3883478D1 (en) Peridinin-chlorophyll complex as a fluorescent identifier.
AU7686094A (en) Method, reagent and kit for the detection of fecal occult blood
CA2285918A1 (en) Methods for concentrating ligands using magnetic particles
EP0701696A4 (en) Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays
CA2132708A1 (en) Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding
WO2004027388A3 (en) Novel green and orange fluorescent labels and their uses
CA2082934A1 (en) Phthalocyanatopolyethylene glycol, and phthalocyanato saccharides as fluorescent digoxin reagents
CA2201153A1 (en) Monoclonal antibody to human cardiac myoglobin
WO2003023357A3 (en) Compounds and methods for fluorescent labeling
AU591636B2 (en) Assay method employing fluorescent cell incorporative dye
AU4213396A (en) Kit for immunologically assaying biological substance and assay process
ATE115729T1 (en) TEST PROCEDURE AND REAGENT KIT THEREFOR.
EP0402846A3 (en) Fluorescence polarization immunoassay for tetrahydrocannabinoids
DE3873877D1 (en) DETERMINATION OF MONOKINES.
CA2008304A1 (en) Assay for bone alkaline phosphatase
BR9300639A (en) MARKING PARTICLES FOR USE IN TESTING A BIOLOGICAL FLUID SAMPLE, PROCESS FOR TESTING A BIOLOGICAL FLUID SAMPLE, AND, PROCESS FOR TESTING A BLOOD SAMPLE
CA2212043A1 (en) Method for assay of analyte by adjustment of chemiluminescence
AU657719B2 (en) Methods for determination of an analyte
CA2065827A1 (en) Multiple color staining reagent and method of analysis
HUP9800782A3 (en) Novel antibody, renin-active substance containing the same and prorenin assay reagent using the same

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed